• Journal of Chest Surgery
• /
• 제57권2호
• /
• pp.184-194
• /
• 2024

Background: Left ventricular assist devices (LVADs) are widely employed as a therapeutic option for end-stage heart failure. We evaluated the outcomes associated with centrifugal-flow LVAD implantation, comparing 2 device models: the Heartmate 3 (HM3) and the Heartware Ventricular Assist Device (HVAD). Methods: Data were collected from patients who underwent LVAD implantation between June 1, 2015 and December 31, 2022. We analyzed overall survival, first rehospitalization, and early, late, and LVAD-related complications. Results: In total, 74 patients underwent LVAD implantation, with 42 receiving the HM3 and 32 the HVAD. A mild Interagency Registry for Mechanically Assisted Circulatory Support score was more common among HM3 than HVAD recipients (p=0.006), and patients receiving the HM3 exhibited lower rates of preoperative ventilator use (p=0.010) and extracorporeal membrane oxygenation (p=0.039). The overall early mortality rate was 5.4% (4 of 74 patients), with no significant difference between groups. Regarding early right ventricular (RV) failure, HM3 implantation was associated with a lower rate (13 of 42 [31.0%]) than HVAD implantation (18 of 32 [56.2%], p=0.051). The median rehospitalization-free period was longer for HM3 recipients (16.9 months) than HVAD recipients (5.3 months, p=0.013). Furthermore, HM3 recipients displayed a lower incidence of late hemorrhagic stroke (p=0.016). In the multivariable analysis, preoperative use of continuous renal replacement therapy (odds ratio, 22.31; p=0.002) was the only significant predictor of postoperative RV failure. Conclusion: The LVAD models (HM3 and HVAD) demonstrated comparable overall survival rates. However, the HM3 was associated with a lower risk of late hemorrhagic stroke.

• Journal of Chest Surgery
• /
• 제54권6호
• /
• pp.543-546
• /
• 2021

A 55-year-old woman who had received an implantable left ventricular assist device 3 months earlier presented with dyspnea and a low-flow alarm of the device. Computed tomography and log-file analysis of the device system suggested inflow cannula obstruction. Since the patient had cardiogenic shock due to pump failure, venoarterial extracorporeal membrane oxygenation (ECMO) was initiated. With ECMO, surgical exchange of the pump was considered. However, the obstruction spontaneously resolved without surgical intervention. It turned out that an obstructive thrombus was washed out by rebooting the pump. Moreover, the thrombus was embolized in the patient's left subclavian artery. The patient underwent heart transplantation 4 months after the pump obstruction accident and continued to do well.

• 대한의용생체공학회:의공학회지
• /
• 제36권4호
• /
• pp.135-142
• /
• 2015

Outflow cannulation site of left ventricular assist device(LVAD) chosen by considering anatomical structure of thoracic cavity and vascular system. Though outflow cannulation site influences blood perfusion at each branch, there is no standard rule or quantitative data. In this study, we computed the amount of blood perfusion at each arterial branch numerically according to outflow cannulation sites(ascending aorta, aortic arch, descending aorta). We generated computational meshes to the three-dimensionally reconstructed arterial system. Clinically measured arterial pressure were used for inlet boundary condition, porous media were applied to mimic blood flow resistance. Blood perfusion through left common carotid artery was 2.5 times higher than other cases, and that through right common carotid artery was 1.1 times higher than other branches. Although this is simulation study, will be useful reference data for the clinical study of LVAD which considers blood perfusion efficiency.

• Journal of Chest Surgery
• /
• 제45권2호
• /
• pp.116-119
• /
• 2012

A 61-year-old female patient was diagnosed with dilated cardiomyopathy with severe left ventricle dysfunction. Two days after admission, continuous renal replacement therapy was performed due to oliguria and lactic acidosis. On the fifth day, an intra-aortic balloon pump was inserted due to low cardiac output syndrome. Beginning 4 days after admission, she was supported for 15 days thereafter with an extracorporeal left ventricular assist device (LVAD) because of heart failure with multi-organ failure. A heart transplant was performed while the patient was stabilized with the LVAD. She developed several complications after the surgery, such as cytomegalovirus pneumonia, pulmonary tuberculosis, wound dehiscence, and H1N1 infection. On postoperative day 19, she was discharged from the hospital with close follow-up and treatment for infection. She received follow-up care for 10 months without any immune rejection reaction.

• Journal of Chest Surgery
• /
• 제29권7호
• /
• pp.689-699
• /
• 1996

신개발한 전기 유압식 심실 보조장치의 생 체 내 성능 테스트와 상기 심실보조장치를 이용한 좌심실 보 조가 자연심장 좌심실의 기능에 미치는 영향을 평가하기 위한 동물실험을 고안하였다. 총 성숙 면양 8마리가 실험에 사용되었으며 이중 7마리로부터 자료 수집이 가능하였다. 심실 보조시 간은69분부터 7일 사이로 심실보조장치는 자연심장의 박동수범위 내에서 동기식 및 비동기식 방식 모 두 만족스럽게 작동하였으며, 좌심방 내의 음압의 발생 없이 주어진 정상 좌심방압 내에서 분당 4리터 이상의 보조 혈류량을 얻을 수 있었다. 심실보조 개시 3일 이후부터 혈중 유리혈색소의 급격한 증가를 보여 상당량의 용혈이 진행되고 있음 을 시사하였다. 또한 심실보조 후 혈액 남의 부동형 고분자판막(floating type polymer valve)에 소량의 혈 전이 발견되어 혈액적 합성 및 혈전저항성 면에 있어 보다 많은 연구 및 개선의 여지가 있음을시사하였 다. 심실보조시작후의 혈역학의 변화는혈류보조량분당2.0∼2.5리터 사이에서 자연심장의 박동수및 박출량과 좌심실 분당작업량(left ventricular minute work), 심내막 생육력비 (endocardial viability ratio), 흔합 정맥혈 및 관상동맥 정맥혈 산소량은 증가하는 소견을 보였으며,반대로 좌심실압 및 좌심방압과 좌심실압 변화율(left ventricular dp/dt)은 감소하는 소견을 보였다. 이중 심박출량의 변화 외에는 모두 통계적으로 유의한 차이를 보여 효과적 인 좌심실의 탈부하가 이루어지고 있음을 입증하였다. 또한 동기식 심실보조시 심내막 생육력비 및 관상정맥혈의 산소량은 비동기식 심실보조시와 비교할 때 역시 통계적으로 유의한 차이를 보여 동기식 심실보조에 의한 반박동(counterpulsation)이 심근의 관 류량을 증가시키며 따라서 손상된 심근의 회복에 유리 함을 시사하였다.

• 대한의용생체공학회:의공학회지
• /
• 제19권1호
• /
• pp.39-46
• /
• 1998

본 연구에서 복잡한 비선형적 특성을 갖는 공압식 좌심실보조장치의 모델링과 제어에 인공신경망을 제안하였다. 일반적으로 좌심실보조장치는 비선형이 보상되어야 하는데 인공신경망은 학습능력에 의해 비선형 동적 시스템의 제어에 적용될 수 있다. 인공신경망 모델링을 통해 좌심실 보조장치의 동적 모델을 모델링하고 이를 기반으로 하여 인공신경망 제어기가 설계되었다. 제안된 알고리즘을 이용한 좌심실보조장치의 모델링과 제어성능 및 유효성은 컴퓨터 시뮬레이션에 의해 증명되었다.

• Advances in biomechanics and applications
• /
• 제1권1호
• /
• pp.23-40
• /
• 2014

This paper examines the blood chamber of a left ventricular assist device (LVAD) under static loading conditions and standard operating temperatures. The LVAD's walls are made of a temperature-sensitive polymer (ChronoFlex C 55D) and are covered with a titanium nitride (TiN) nano-coating (deposited by laser ablation) to improve their haemocompatibility. A loss of cohesion may be observed near the coating-substrate boundary. Therefore, a micro-scale stress-strain analysis of the multilayered blood chamber was conducted with FE (finite element) code. The multi-scale model included a macro-model of the LVAD's blood chamber and a micro-model of the TiN coating. The theories of non-linear elasticity and elasto-plasticity were applied. The formulated problems were solved with a finite element method. The micro-scale problem was solved for a representative volume element (RVE). This micro-model accounted for the residual stress, a material model of the TiN coating, the stress results under loading pressures, the thickness of the TiN coating and the wave parameters of the TiN surface. The numerical results (displacements and strains) were experimentally validated using digital image correlation (DIC) during static blood pressure deformations. The maximum strain and stress were determined at static pressure steps in a macro-scale FE simulation. The strain and stress were also computed at the same loading conditions in a micro-scale FE simulation.

• 제어로봇시스템학회:학술대회논문집
• /
• 제어로봇시스템학회 1995년도 Proceedings of the Korea Automation Control Conference, 10th (KACC); Seoul, Korea; 23-25 Oct. 1995
• /
• pp.514-517
• /
• 1995

A new stroke output control algorithm with a fuzzy logic for an electrohydraulic left ventricular assist device(EH-LVAD) was developed. The EH-LVAD pumps out blood from left atrium actively. Excessive suction of blood may cause fatal damage in left atrium. The LVAD has to provide a maximal stroke output without collapse of left atrium. In this study a new fuzzy algorithm for predicting and detecting suction and doing proper action on LVAD without using an extra pressure sensor but with bellows pressure signal and motor current signal is developed. The performance of the fuzzy control algorithm is demonstrated by the results from mock circulatory experiments.

• 대한의용생체공학회:의공학회지
• /
• 제22권4호
• /
• pp.349-358
• /
• 2001

A novel electro-mechanical implantable ventricular assist system is developed as a bridge to transplantation or recovery for patients with end-stage heart failure. The developed system is composed of an implanted blood pump, an external monitoring system which stores data, and a wearable system including a portable external driver and a portable power supply system. The blood pump is designed to be implanted into the left upper abdominal space and provides blood flow from the left ventricular apex to the aorta. The pulsatile blood flow is generated by a double cylindrical cam. There was mo excessive heat emission from the blood pump into the temperature-controlled chamber in the heat test and no stagnated flow within the blood sac by the observation in the flow visualization test. Animal experiments were performed using sheep and calves. The maximum assist flow rate reached 7.85L/min in the animal experiment. The evaluation results showed that the developed system was feasible for the implantable ventricular assist system. The long-term in vitro durability test and mid-term in vivo experiments are in progress and mow the modified next model is under development.

• Journal of Chest Surgery
• /
• 제53권5호
• /
• pp.306-309
• /
• 2020

A 59-year-old man presented for possible durable ventricular assist device (VAD) implantation. He had previously been diagnosed with congenitally corrected transposition of the great arteries, a ventricular septal defect, an atrial septal defect, pulmonary valve stenosis, and aortic valve regurgitation. In the previous 22 years, he had undergone palliative cardiac surgery 3 times. VAD implantation as a bridge to transplantation was planned. Owing to severe adhesions, mesocardia, a left ascending aorta, and moderate aortic regurgitation, we performed VAD implantation and aortic valve closure via a dual left thoracotomy and partial sternotomy.